Cingulate (NASDAQ:CING – Get Free Report) is expected to release its earnings data before the market opens on Monday, March ...

KANSAS CITY, Kan., March 04, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery ...

Abbott Neuromodulation's Jenn Wong discusses the TRANSCEND trial for depression, imaging tech advancing DBS and other ...

The parts of the brain that are needed to remember words, and how these are affected by a common form of epilepsy, have been ...

A new study has identified brain regions crucial for remembering words and how they are affected in people with temporal lobe ...

Cingulate (NASDAQ:CING – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued to investors on Thursday,Benzinga reports. They ...

Cingulate Inc. submitted CTx-1301 Phase 3 safety data to the FDA, preparing for a Pre-NDA meeting on April 2, 2025. Cingulate Inc. announced the submission of Phase 3 safety data for its ADHD ...

The parts of the brain needed to remember words have been identified. Those areas are affected by a common form of epilepsy, ...

The subtleties involved here reflect the fact that the brain’s dizzying complexity means it’s rarely possible to draw simple conclusions. Even in this case, where a basic interpretation might be that ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of ...